AC
PETS icon

Aperimus Capital’s PetMed Express PETS Stock Holding History

Aperimus Capital’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$608K Buy
+19,100
New +$607K 0.98% 15

Other funds holding PETS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Aperimus Capital's PETS Position: Q2 2021 in Review

Aperimus Capital opened a new position in PetMed Express (PETS) in Q2 2021: 19,100 shares worth $608K. The stake represents 0.98% of the portfolio and ranks #15 among its holdings.

198 funds tracked by Wall St. Rank hold PETS as of Q2 2021.

  • Aperimus Capital held 19,100 shares of PetMed Express worth $608K as of Q2 2021.
  • PetMed Express was a new Aperimus Capital position in Q2 2021.
  • PetMed Express made up 0.98% of Aperimus Capital's portfolio in Q2 2021, its #15 holding.
  • 198 funds tracked by Wall St. Rank held PetMed Express as of Q2 2021.

Based on Aperimus Capital's 13F filing for Q2 2021, filed 28 Jul 2021.